Charles River Laboratories International, Inc. (CRL)
$301.79+1.27%Close
BUYBULL · day 12
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $14.5B
- Beta
- 1.41
- P/E (TTM)
- -63.01
- Short % float
- 6.04%
- Days to cover
- 2.7
- SI change
- +29.1%
- 1W
- +4.00%
- 1M
- +10.55%
- vs SPY 1W
- +2.84%
- vs SPY 1M
- +7.55%
Industry peers
FMP comparable companies · ranked by market cap
- 2268.HKWuXi XDC Cayman Inc$106.1B$83.75
- WUXIFWuXi AppTec Co., Ltd.$80.6B$27.00
- 300759.SZPharmaron Beijing Co., Ltd.$61.8B$41.80
- 603127.SSJoinn Laboratories(China)Co.,Ltd.$38.0B$50.73
- WXIBFWuXi Biologics (Cayman) Inc.$28.0B$6.75
- MEDPSELLMedpace Holdings, Inc.$17.3BBULLQ 47$620.05+1.55%
- ICLRSELLICON Public Limited Company$12.6BRECOVERYQ 17$164.40-0.20%
- GNNSFGenscript Biotech Corporation$12.0B$5.50
- HNGZYHangzhou Tigermed Consulting Co., Ltd$6.9B$4.45
- CERTBUYCertara, Inc.$1.4BBEARQ -11$9.24+5.67%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on CRL?
- LOPJLB’s latest quantitative signal on Charles River Laboratories International, Inc. (CRL) is BUY in a BULL regime. Signals are updated daily.
- What market regime is CRL in?
- Charles River Laboratories International, Inc. (CRL) is currently classified in the BULL HMM market regime on LOPJLB.
- What does Charles River Laboratories International, Inc. (CRL) do?
- Charles River Laboratories International, Inc. operates as a contract research organization (CRO), providing essential preclinical services to the pharmaceutical and biotechnology industries. Its core business revolves around assisting clients with drug discovery, non-clinical development, and thorough safety testing, with its services extending globally across the United States, Europe, Canada…